Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v2.4.0.8
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenues        
Product $ 3,456 $ 3,890 $ 6,177 $ 7,674
Product licensing fees 397 374 830 406
Service 236 262 454 497
Total revenues 4,089 4,526 7,461 8,577
Cost of revenues        
Product 1,203 1,092 2,224 2,080
Service 181 234 332 413
Total cost of revenues 1,384 1,326 2,556 2,493
Gross profit 2,705 3,200 4,905 6,084
Operating expenses        
Research and development 883 513 1,390 1,045
Selling, general and administrative 3,093 3,504 5,912 6,351
Total operating expenses 3,976 4,017 7,302 7,396
Loss from operations (1,271) (817) (2,397) (1,312)
Interest expense (188) (280) (438) (568)
Interest income 0 1 1 2
Gain (loss) due to change in fair value of common stock (See Note 3) 99 0 (210) 0
(Loss) gain due to change in fair value of derivative instruments 0 (397) 0 850
Other expense, net (39) (26) (67) (46)
Net loss (1,399) (1,519) (3,111) (1,074)
Preferred stock deemed dividend 0 0 0 (1,062)
Net loss available to common shareholders (1,399) (1,519) (3,111) (2,136)
Net loss per common share: basic and diluted $ (0.21) $ (0.33) $ (0.47) $ (0.47)
Weighted-average number of shares used in per common share calculations:        
Basic and diluted 6,631 4,659 6,625 4,587
Other comprehensive loss        
Net loss (1,399) (1,519) (3,111) (1,074)
Foreign currency translation adjustments 13 119 (86) (1)
Other comprehensive loss $ (1,386) $ (1,400) $ (3,197) $ (1,075)